by Market Overview:
Southern blotting is a technique used to detect specific DNA sequences in DNA samples run through agarose gel electrophoresis. It is commonly used for detection of the presence of a particular gene within a DNA sample or to determine the size or copy number of a sequence within a genome.
The global Southern Blotting Market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the Southern blotting market is the shift from traditional Southern blotting to rapid Southern blotting. Rapid Southern blotting helps to save time significantly in analyzing DNA fragments. The technique utilizes advance chemiluminescent detection probes and membranes that help in detecting target DNA in less than 4 hours as compared to traditional technique taking over 24 hours. This significantly improves throughput and efficiency in molecular biology research and molecular diagnostics.
SWOT Analysis
Strength: Southern blotting provides accurate and reliable results, enabling researchers to study gene expression and mutations. It is highly specific and sensitive technique.
Weakness: Southern blotting is time-consuming technique requiring several days to complete and yielding relatively low throughput. It requires large amounts of high-quality nucleic acid extracts.
Opportunity: Increasing adoption of southern blotting in molecular diagnosis of genetic disorders and detection of viral and bacterial pathogens is creating growth opportunities. Growing genomic research activities are also fueling demand.
Threats: Availability of alternative techniques like PCR and DNA microarrays that offer higher sensitivity and throughput poses threats to southern blotting. High costs associated with southern blotting kits and reagents is also a challenge.
Key Takeaways
The global Southern Blotting Market Growth is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period, due to increasing R&D investments in genomics and molecular diagnostics.
Regional analysis
North America is expected to dominate the global southern blotting market during the forecast period owing to significant funding and investments for genomics and biotech research in the region. Asia Pacific is anticipated to exhibit fastest growth attributed to rising research activities, growing awareness and improving healthcare infrastructure in the region.
Key players operating in the Southern Blotting Market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Agilent Technologies, PerkinElmer, GE Healthcare, Promega Corporation, Genetec, Bio-Rad Laboratories, Abcam. New product launches, expansions and collaborations are some key strategies adopted by market players to gain competitive edge.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
